The Brain Cancer Centre welcomes a proposed $16 million election commitment from the Victorian Liberal Party to support greater access to innovative clinical trials, precision medicine and potential new treatments for brain cancer patients.
Announced at WEHI, the commitment would support the next phase of the Brain Perioperative Program (BrainPOP), strengthening efforts to improve outcomes for brain cancer patients and families.
Founded by Carrie’s Beanies 4 Brain Cancer, The Brain Cancer Centre was established in 2021 in partnership with WEHI with support from the Victorian Government.
“Brain cancer remains one of the most challenging cancers to treat. Continued investment in collaborative research is key to developing innovative trials and treatments to improve outcomes for patients. We welcome this commitment to funding more clinical trials for more Victorian patients.”
Sam McGuane, CEO The Brain Cancer Centre
BrainPOP accelerates brain cancer research
Established by The Brain Cancer Centre, BrainPOP brings together leading clinicians and researchers from across the Parkville biomedical precinct to accelerate the development of new brain cancer treatments and expand clinical trial opportunities for Victorian children and adults.
This unique collaboration between WEHI, the Royal Melbourne Hospital, Peter MacCallum Cancer Centre (Peter Mac), the Royal Children’s Hospital, Murdoch Children’s Research Institute, and the University of Melbourne connects world-leading research expertise with specialist clinical care, enabling Victorians with brain cancer to access innovative clinical trials and emerging therapies.
Through BrainPOP, precision medicine helps identify the treatments and clinical trials most relevant to each patient, while research conducted around the time of surgery allows researchers to study how new therapies work directly in tumour tissue. Together these approaches help identify promising treatments, accelerate discoveries and bring new personalised therapeutic opportunities to patients sooner.
“When my husband was diagnosed in 2000, there wasn’t a clinical trial available to us. We had the standard treatment of the time: major surgery to remove most of the tumour, followed by aggressive chemotherapy and radiation. There was no hope.”
“Today, families facing that diagnosis in Melbourne have access to sophisticated tumour testing to understand what is unique about their disease, and may be able to access a clinical trial relevant to them. BrainPOP gives patients and their families something incredibly important: hope.”
Carrie Bickmore OAM, Founder and Chair, Carrie’s Beanies 4 Brain Cancer
Turning research advances into new treatment opportunities
Despite advances in research and treatment, survival rates for patients with brain cancer have barely improved in 30 years. 80% of patients diagnosed with brain cancer will die within five years. More children die from brain cancer in Australia than any other disease.
Associate Professor Jim Whittle, laboratory head at The Brain Cancer Centre and WEHI, and a medical oncologist specialising in neuro-oncology at Peter Mac, said that while brain cancer remains difficult to treat, translating promising research discoveries into effective treatments for patients is complex.
“The challenge in brain cancer is not simply discovering promising new treatments but finding ways to test them in patients and understanding which therapies are most likely to work.”
“BrainPOP brings together the expertise needed to bridge that gap, accelerating the development of new treatments and creating more opportunities for Victorians to access innovative clinical trials.”
A/Prof Jim Whittle, The Brain Cancer Centre, WEHI, Peter Mac
Sam McGuane, CEO The Brain Cancer Centre; Prof Ken Smith, WEHI; Georgie Crozier MP; Jess Wilson MP; Carrie Bickmore OAM
Carrie Bickmore OAM
Jess Wilson MP
Prof Misty Jenkins, The Brain Cancer Centre and WEHI; Prof Ken Smith, WEHI; Jess Wilson MP; A/Prof Jim Whittle, The Brain Cancer Centre, WEHI and Peter MacCallum Cancer Centre; Georgie Crozier MP; Dr Sarah Best, The Brain Cancer Centre and WEHI
A/Prof Jim Whittle, The Brain Cancer Centre, WEHI and Peter MacCallum Cancer Centre
Prof Misty Jenkins, The Brain Cancer Centre and WEHI
A/Prof Jim Whittle, The Brain Cancer Centre, WEHI and Peter MacCallum Cancer Centre


